for on the and and call good TFF programs. three everyone. government our ongoing areas of growth key pharma shared Bill I contracting growing and internal Two, focused afternoon efforts three, efforts the the partnering development team and efforts. company. of our a with TFF everyone Thanks level Last the laser of one, high business earnings foundation These are perspective are, development pipeline
We of each continue to in make great key these strides areas.
will our TFF we focus a includes exciting today's I with it at partnering pharma updates. For on few process provide and BD call The the define process efforts, everyone steps. following the as use we
into enter a confidentiality partner. with and we agree a we First collaborate the on testing. compound for Then agreement
the examples. samples confirm testing performs into activity, We may dry the for of be and/or materials upon work powder testing, of we BD immunogenicity dry and as powder receipt on in-vitro you our partners samples, their of dry formulations. cell partner with few some material a a process compound the transfection selection knock technology. give partner down statement of collaborate we characterization to formulation culture powder partner's are perform run partner, flavor some the the and/or of of and we optimal in here enter batch of with have work the status do Next, deliver formulation proprietary the agreement, a transfer the To performing perform some and aerosol the our been initial work, a case to work, optimization work the or then then our a an
to after this viability proprietary to we of phage our partners [phage] confirm showed await dry ongoing of eagerly dry samples testing [phage] of our superior our delivered powder a to We candidate We the which into and the the the Just able week were earlier properties. successfully results product before activity powder aerosol TFF formulate TFF process. partners partner.
performed DNA. party in proprietary lab. a of we testing so addition, are are being the our at or powder partner's ongoing They our plasmid dried expecting In the of week next samples assay readout currently third TF plaque testing
of We are very results testing. to the this receive eager
support that will will only and which licensing will results and We confirmatory a include between confirm are these very next technology this hopeful our testing not companies. effective also that that was validate our but agreement collaboration steps respective
as one were proprietary monoclonal everyone superior showed and partner's we monoclonal lung. SiRNA, successfully mRNA, of [maps] partners example, our week give more aerosol dry products bacteria, be delivery plasmid for bacteriophage antibodies. summary, next dry to to to their able powder which delivering samples properties on multiple working into partner Just to proprietary early are DNA, the with In antibodies, various proprietary vaccines. we formulate our powder such will We a
We the for formulating dry biologics into their are proprietary TFF a lungs. powder inhalation delivery to directly
collaborations. our We and of excited to potential upfront Freezing very feasibility partner TFF a Film respective milestones partners. then would the include would agreement of successful are for into these granting development license future collaboration each arrangements and development work payment, with technology would goal these a in and These our Thin include full-blown the be Upon enter an to royalties turn pharma. to
and collaborator. our critical partner strongest While think is thank I it I opportunity, have this to
these the Texas Austin. the efforts All our at by of at business University of supported of tireless development collaboration partners efforts are
Film now Bill Thin With our the that new only over Williams we Thank a of In of the the are the time. Glenn. we continue hand applications surface have I the our We excited the innovative of expand team said, of technology Freezing the you many BD areas about applications company. very we growth back all his opportunities for With scratched technology and Dr. to support of research believe your Film closing, perspective and delivery. will technology. Thin it and drug of into of from Freezing to
